InvestorsHub Logo
Followers 900
Posts 198051
Boards Moderated 3
Alias Born 05/10/2004

Re: None

Wednesday, 08/15/2018 1:04:16 PM

Wednesday, August 15, 2018 1:04:16 PM

Post# of 857
just saw it surprised not more action here is the news


ioneer Green USA Enters into Two CBD Store License Agreements in Florida



Toronto, Ontario (FSCwire) - Oxford Investments Holdings Inc. (“Oxford” or the “Company”) (OTCMKTS: OXIHF) is pleased to announce that its US-based subsidiary, FloraCana Consultants, Inc. (“FloraCana”), operating under the name of “Pioneer Green USA”, has entered into two license agreements in Florida.

The first two license agreements include a store in Palm Harbor, which is expected to open in mid-August, and the second store in Bradenton is expected to open by early September. FloraCana is also pursuing distribution agreements to provide specialty CBD formulations for specific market segments and niches.

Under the terms of the license agreement, the licensee is responsible for the lease of their storefront. The licensee engages FloraCana to set up a turn-key Pioneer Green USA branded store and stock it with a variety of CBD products ranging from oils, vaporizers, salves and ointments which are white-labelled specifically for Pioneer Green USA from multiple suppliers. By agreement, licensees are obligated to purchase Pioneer Green CBD products on an ongoing basis.

“We are excited to be opening these stores. We believe that CBD will be one of the most promising opportunities in 2018 because CBD is expected to be one of the fastest growing industries in the US over the next three to five years as more people become aware of the potential health and wellness benefits of CBD.” stated Michael Donaghy, President of Oxford. “We are looking to expand our concept into other states and strive to make Pioneer Green USA into a nationally recognized brand.”

The CBD market is a large part of the legal cannabis industry. The Hemp Business Journal estimates that the CBD market will grow to a 2.1 billion USD market in consumer sales by 2020 with $450 million USD of those sales coming from hemp-based sources. That is a 700% increase from 2016. In 2015, the market for consumer sales of hemp-derived CBD products was $90 million USD.

CBD (Cannabidiol) is a hemp-derived compound that has potentially significant medical benefits to human and animal health and wellness. Scientific and clinical research, often supported by academia, the US government, and the World Health Organization, which has concluded that CBD offers a range of medical health benefits without the potential to be abused or cause harm in users. This makes it an appealing option for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and other conditions without disconcerting feelings of tiredness or feeling “stoned”.

CBD that is derived from hemp is legal to import and purchase in all 50 U.S. states, without a prescription. Unlike THC and marijuana, Cannabidiol itself isn’t listed in the Controlled Substances Act.

Interested parties are encouraged to call (416)-576-4671 to request information, book an appointment, or visit the office:

FloraCana Consultants, Inc.

(Pioneer Green USA)
600 8th Avenue West, Suite 303
Palmetto, Florida, USA
34221
(727)-313-5289

Contacts:

Oxford Investments Holdings Inc.

Michael Donaghy 1-416-576-4671

Website: www.oxsof.com